Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BK1310 DPT-IPV-Hib vaccine in healthy infants
NCT03188692Phase 3Completed
- Sponsor
- Mitsubishi Tanabe Pharma
- Start
- Jun 2017
- Primary completion
- Nov 2017
- Modality
- Therapeutic Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of MT-2355 in diphtheria, pertussis, Tetanus, poliomyelitis, Haemophilus influenzae type b infection (Hib), sponsored by Mitsubishi Tanabe Pharma. Started Jun 2017; status: completed.
02
Drugs
MT-2355
03
Conditions
diphtheriapertussisTetanuspoliomyelitisHaemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT03188692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03188692.